skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

28 Total results for product and free and sample content found

Scrip

Precious Cargo: DHL Gears To Deliver COVID-19 Vaccines

08 Dec 2020

DHL Covid-19 Vaccines

A senior executive shares insights around how the global logistics provider is preparing to deliver the upcoming COVID-19 vaccines across the world. While the company has prior experience with the "deep frozen" temperatures needed for some candidates, there will still be specific challenges and complexities involved. 

Topic Coronavirus Vaccines Distribution

Pink Sheet

Vaccine Distribution Priorities To Rely On Governors, Not ACIP, HHS Secretary Azar Says

By Derrick Gingery 29 Nov 2020

covid19 vaccines distribution

Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated

Topic Vaccines Coronavirus Distribution

Scrip

Quick Listen: Scrip's Five Must-Know Things

By Ian Haydock 29 Nov 2020

Scrip August Podcast

Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things

Topic Coronavirus Research & Development Vaccines

Scrip

Oxford/AZ's COVID-19 Vaccine Cuts Virus Spread By 60%

By Vibha Sharma 29 Nov 2020

Covid19 Vaccine oxfordAZ

Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.

Topic Coronavirus Vaccines

Pink Sheet

For Coronavirus US FDA Is At The Podium But Not On The Task Force

By Derrick Gingery 27 Nov 2020

Hahn speaks at Coronavirus briefing

The FDA is curiously not one of the HHS entities coordinating the US response to the outbreak, but must monitor for manufacturing disruptions and shortages, as well as approve new treatments and diagnostics.

Topic FDA Vaccines Infectious Diseases Coronavirus

Scrip

Coronavirus Update: Moderna In Advanced Talks With Europe On Vaccine Supplies

By Scrip Team 27 Nov 2020

Moderna Talks To Europe ON Vaccine Supplies Covid19

The deal would include an option for expansion to 160 million doses of the mRNA-based vaccine.

Topic Coronavirus Clinical Trials Vaccines

Pink Sheet

Coronavirus Efforts Could Benefit From Little-Used Medical Countermeasures Incentives

By Bridget Silverman 27 Nov 2020

Coronavirus Efforts Could Benefit From Little-Used Medical Countermeasures Incentives

US FDA’s Medical Countermeasures Initiative authorities like emergency use authorization have not yet had much of an impact on drugs and biologics, but agency is committed to supporting a swift response to the new strain of coronavirus.

Topic Infectious Diseases Vaccines Coronavirus

Scrip

AstraZeneca's COVID Vaccine On Hold: A Reminder Drug Development Is Never Straightforward

By Jessica Merrill 27 Nov 2020

Coronavirus Drug on Hold

The company – one of the frontrunners in the race to develop a COVID-19 vaccine – has voluntarily put a hold on the Phase III trial due to an adverse event.

Topic Coronavirus Vaccines

Datamonitor Healthcare

Priority Populations For COVID-19 Vaccination: Global Timelines For Deployment

17 Nov 2020

COVID-19 Vaccine

As the COVID-19 pandemic continues, governments worldwide have pinned their hopes on returning to normality on the development of a vaccine. With multiple vaccines currently in late-stage trials, there is promise that a successful vaccine will soon be ready.

Topic Coronavirus Vaccines

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: